UnitedHealth (UNH) enters its October 13, 2026, Q3 earnings release with an 82% market-implied probability of beating consensus estimates of roughly $4.12–$4.15 EPS on $111.3 billion revenue. The high odds reflect the company’s consistent outperformance, including a 29% beat in Q2 2026 and upward revisions to full-year adjusted EPS guidance of $19.50–$20.00 after strong Medicare Advantage margin expansion and Optum Health operating leverage. Traders are pricing in continued momentum from favorable medical loss ratio trends near 90% and potential Optum upside, tempered by modest revenue contraction from portfolio adjustments. The release could also include initial 2027 commentary, a key swing factor for sentiment.